Stephen L. Holcombe

2017

In 2017, Stephen L. Holcombe earned a total compensation of $1.2M as President and Chief Executive Officer at vTv Therapeutics, a 83% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$95,625
Option Awards$691,516
Salary$450,000
Other$8,721
Total$1,245,862

Holcombe received $691.5K in option awards, accounting for 56% of the total pay in 2017.

Holcombe also received $95.6K in non-equity incentive plan, $450K in salary and $8.7K in other compensation.

Rankings

In 2017, Stephen L. Holcombe's compensation ranked 7,925th out of 14,666 executives tracked by ExecPay. In other words, Holcombe earned more than 46.0% of executives.

ClassificationRankingPercentile
All
7,925
out of 14,666
46th
Division
Manufacturing
2,974
out of 5,772
49th
Major group
Chemicals And Allied Products
974
out of 2,075
53rd
Industry group
Drugs
760
out of 1,731
56th
Industry
Pharmaceutical Preparations
597
out of 1,333
55th
Source: SEC filing on March 16, 2018.

Holcombe's colleagues

We found three more compensation records of executives who worked with Stephen L. Holcombe at vTv Therapeutics in 2017.

2017

Larry Altstiel

vTv Therapeutics

Chief Medical Officer

2017

Rudy Howard

vTv Therapeutics

Chief Financial Officer

2017

Jeffrey Kindler

vTv Therapeutics

Chairman

News

In-depth

You may also like